Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 2/2018

01-12-2018 | Research Article

The influence of patient variables on insulin total daily dose in paediatric inpatients with new onset type 1 diabetes mellitus

Authors: Marion Muller, Benjamin J. Wheeler, Miranda Blackwell, Mathilde Colas, David M. Reith, Natalie J. Medlicott, Hesham S. Al-Sallami

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2018

Login to get access

Abstract

Purpose

Insulin dose requirements at new diagnosis of type 1 diabetes mellitus (T1DM) vary widely. Current guidelines recommend an initial total daily dose (TDD) ranging from 0.5 to 1.0 IU/kg/day. It often takes several days of frequent dose adjustments before an optimal insulin dose is achieved. The aim of this study was to identify the influence of patient variables on the dose-requirement of insulin in newly diagnosed children with T1DM.

Methods

A retrospective chart review of children (≤ 18 years old) admitted to hospital between 2010 and 2016 due to new onset T1DM was undertaken. Demographic, clinical, insulin dosing, and laboratory data were recorded. The influence of patient characteristics on insulin TDD was analysed statistically by performing univariate and multivariate linear regression analyses.

Results

Complete clinical records for 70 patients were available for analysis. The median insulin TDD on first day of admission was 21 (4.5 to 75 units) and that on the day before discharge was 27 (5.5 to 124 units). In the multivariate regression analysis, body size (total body weight and fat-free mass), glycated haemoglobin (HbA1C), and blood ketone concentration were found to be significant predictors of optimal insulin TDD (p < 0.05).

Conclusion

In addition to body size, HbA1c and ketone concentrations are useful in calculating initial TDD in newly diagnosed children with T1DM. This could potentially decrease the number of days needed to reach a stable dose and result in improved early glycaemic control.
Literature
1.
go back to reference Rodbard D. Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes Technol Ther. 2016;18(Suppl 2):S3–S13.PubMed Rodbard D. Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes Technol Ther. 2016;18(Suppl 2):S3–S13.PubMed
2.
go back to reference Selvakumar D, Al-Sallami HS, de Bock M, Ambler GR, Benitez-Aguirre P, Wiltshire E, et al. Insulin regimens for newly diagnosed children with type 1 diabetes mellitus in Australia and New Zealand: a survey of current practice. J Paediatr Child Health. 2017;53(12):1208–14.CrossRefPubMed Selvakumar D, Al-Sallami HS, de Bock M, Ambler GR, Benitez-Aguirre P, Wiltshire E, et al. Insulin regimens for newly diagnosed children with type 1 diabetes mellitus in Australia and New Zealand: a survey of current practice. J Paediatr Child Health. 2017;53(12):1208–14.CrossRefPubMed
3.
go back to reference Phelan H, Clapin H, Bruns L, Cameron FJ, Cotterill AM, Couper JJ, et al. The Australasian diabetes data network: first national audit of children and adolescents with type 1 diabetes. Med J Aust. 2017;206(3):121–5.CrossRefPubMed Phelan H, Clapin H, Bruns L, Cameron FJ, Cotterill AM, Couper JJ, et al. The Australasian diabetes data network: first national audit of children and adolescents with type 1 diabetes. Med J Aust. 2017;206(3):121–5.CrossRefPubMed
4.
go back to reference Danne T, Bangstad HJ, Deeb L, Jarosz-Chobot P, Mungaie L, Saboo B, et al. ISPAD clinical practice consensus guidelines 2014. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(Suppl 20):115–34.CrossRefPubMed Danne T, Bangstad HJ, Deeb L, Jarosz-Chobot P, Mungaie L, Saboo B, et al. ISPAD clinical practice consensus guidelines 2014. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(Suppl 20):115–34.CrossRefPubMed
5.
go back to reference Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, et al. American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Endocr Pract. 2015;21(Suppl 1):1–87.CrossRefPubMedPubMedCentral Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, et al. American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Endocr Pract. 2015;21(Suppl 1):1–87.CrossRefPubMedPubMedCentral
6.
go back to reference Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28(1):186–212.CrossRefPubMed Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28(1):186–212.CrossRefPubMed
7.
go back to reference Arai K, Yokoyama H, Okuguchi F, Yamazaki K, Takagi H, Hirao K, et al. Association between body mass index and core components of metabolic syndrome in 1486 patients with type 1 diabetes mellitus in Japan (JDDM 13). Endocr J. 2008;55(6):1025–32.CrossRefPubMed Arai K, Yokoyama H, Okuguchi F, Yamazaki K, Takagi H, Hirao K, et al. Association between body mass index and core components of metabolic syndrome in 1486 patients with type 1 diabetes mellitus in Japan (JDDM 13). Endocr J. 2008;55(6):1025–32.CrossRefPubMed
8.
go back to reference Klinkert C, Bachran R, Heidtmann B, Grabert M, Holl RW. Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII. Exp Clin Endocrinol Diabetes. 2008;116(2):118–22.CrossRefPubMed Klinkert C, Bachran R, Heidtmann B, Grabert M, Holl RW. Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII. Exp Clin Endocrinol Diabetes. 2008;116(2):118–22.CrossRefPubMed
9.
go back to reference Cemeroglu A, Thomas J, Zande L, Nguyen N, Wood M, Kleis L, et al. Basal and bolus insulin requirements in children, adolescents, and young adults with type 1 diabetes mellitus on continuous subcutaneous insulin infusion (CSII): effects of age and puberty. Endocr Pract. 2013;19(5):805–11.CrossRefPubMed Cemeroglu A, Thomas J, Zande L, Nguyen N, Wood M, Kleis L, et al. Basal and bolus insulin requirements in children, adolescents, and young adults with type 1 diabetes mellitus on continuous subcutaneous insulin infusion (CSII): effects of age and puberty. Endocr Pract. 2013;19(5):805–11.CrossRefPubMed
10.
go back to reference Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty. N Engl J Med. 1986;315(4):215–9.CrossRefPubMed Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty. N Engl J Med. 1986;315(4):215–9.CrossRefPubMed
11.
go back to reference Bloch CA, Clemons P, Sperling MA. Puberty decreases insulin sensitivity. J Pediatr. 1987;110(3):481–7.CrossRefPubMed Bloch CA, Clemons P, Sperling MA. Puberty decreases insulin sensitivity. J Pediatr. 1987;110(3):481–7.CrossRefPubMed
12.
go back to reference Wiegand S, Raile K, Reinehr T, Hofer S, Näke A, Rabl W, et al. Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, gender, body mass index and mode of therapy. Eur J Endocrinol. 2008;158(4):543–9.CrossRefPubMed Wiegand S, Raile K, Reinehr T, Hofer S, Näke A, Rabl W, et al. Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, gender, body mass index and mode of therapy. Eur J Endocrinol. 2008;158(4):543–9.CrossRefPubMed
13.
go back to reference Thnc O, Cetinkaya S, Kizilgun M, Aycan Z. Vitamin D status and insulin requirements in children and adolescent with type 1 diabetes. J Pediatr Endocrinol Metab. 2011;24(11–12):1037–41.PubMed Thnc O, Cetinkaya S, Kizilgun M, Aycan Z. Vitamin D status and insulin requirements in children and adolescent with type 1 diabetes. J Pediatr Endocrinol Metab. 2011;24(11–12):1037–41.PubMed
14.
go back to reference The N, Crandell J, Lawrence J, King I, Dabelea D, Marcovina S, et al. Vitamin D in youth with type 1 diabetes: prevalence of insufficiency and association with insulin resistance in the SEARCH nutrition ancillary study. Diabet Med. 2013;30(11):1324–32.CrossRefPubMedPubMedCentral The N, Crandell J, Lawrence J, King I, Dabelea D, Marcovina S, et al. Vitamin D in youth with type 1 diabetes: prevalence of insufficiency and association with insulin resistance in the SEARCH nutrition ancillary study. Diabet Med. 2013;30(11):1324–32.CrossRefPubMedPubMedCentral
15.
go back to reference Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011;17(5):610–7.CrossRefPubMedPubMedCentral Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011;17(5):610–7.CrossRefPubMedPubMedCentral
16.
go back to reference Johnson JL. Diabetes control in thyroid disease. Diabetes Spectr. 2006;19(3):148–53.CrossRef Johnson JL. Diabetes control in thyroid disease. Diabetes Spectr. 2006;19(3):148–53.CrossRef
17.
go back to reference Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098.PubMed Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098.PubMed
18.
go back to reference Al-Sallami HS, Goulding A, Grant A, Taylor R, Holford N, Duffull SB. Prediction of fat-free mass in children. Clin Pharmacokinet. 2015;54(11):1169–78.CrossRefPubMed Al-Sallami HS, Goulding A, Grant A, Taylor R, Holford N, Duffull SB. Prediction of fat-free mass in children. Clin Pharmacokinet. 2015;54(11):1169–78.CrossRefPubMed
19.
go back to reference Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58(2):259–63.PubMed Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58(2):259–63.PubMed
20.
go back to reference Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr. 1985;106(3):522–6.CrossRefPubMed Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr. 1985;106(3):522–6.CrossRefPubMed
22.
go back to reference Wolfsdorf JI, Allgrove J, Craig ME, Edge J, Glaser N, Jain V, et al. ISPAD clinical practice consensus guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014;15(Suppl 20):154–79.CrossRefPubMed Wolfsdorf JI, Allgrove J, Craig ME, Edge J, Glaser N, Jain V, et al. ISPAD clinical practice consensus guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014;15(Suppl 20):154–79.CrossRefPubMed
23.
go back to reference Szadkowska A, Pietrzak I, Mianowska B, Bodalska-Lipińska J, Keenan H, Toporowska-Kowalska E, et al. Insulin sensitivity in type 1 diabetic children and adolescents. Diabet Med. 2008;25(3):282–8.CrossRefPubMed Szadkowska A, Pietrzak I, Mianowska B, Bodalska-Lipińska J, Keenan H, Toporowska-Kowalska E, et al. Insulin sensitivity in type 1 diabetic children and adolescents. Diabet Med. 2008;25(3):282–8.CrossRefPubMed
24.
go back to reference Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49(4):626–32.CrossRefPubMed Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49(4):626–32.CrossRefPubMed
25.
go back to reference Dahlquist G, Blom L, Bolme P, Hagenfeldt L, Lindgren F, Persson B, et al. Metabolic control in 131 juvenile-onset diabetic patients as measured by HbA1c: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections. Diabetes Care. 1982;5(4):399–403.CrossRefPubMed Dahlquist G, Blom L, Bolme P, Hagenfeldt L, Lindgren F, Persson B, et al. Metabolic control in 131 juvenile-onset diabetic patients as measured by HbA1c: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections. Diabetes Care. 1982;5(4):399–403.CrossRefPubMed
26.
go back to reference Clarson C, Daneman D, Drash AL, Becker DJ, Ehrlich RM. Residual β-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve. Diabetes Care. 1987;10(1):33–8.CrossRefPubMed Clarson C, Daneman D, Drash AL, Becker DJ, Ehrlich RM. Residual β-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve. Diabetes Care. 1987;10(1):33–8.CrossRefPubMed
27.
go back to reference Weitzela D, Pfeffera U, Dost A, Herbstc A, Knerr I, Holl R. Initial insulin therapy in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2010;11(3):159–65.CrossRefPubMed Weitzela D, Pfeffera U, Dost A, Herbstc A, Knerr I, Holl R. Initial insulin therapy in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2010;11(3):159–65.CrossRefPubMed
28.
go back to reference Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999;15(6):412–26.CrossRefPubMed Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999;15(6):412–26.CrossRefPubMed
29.
go back to reference Moran A, Jacobs DR Jr, Steinberger J, Hong CP, Prineas R, Luepker R, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48(10):2039–44.CrossRefPubMed Moran A, Jacobs DR Jr, Steinberger J, Hong CP, Prineas R, Luepker R, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48(10):2039–44.CrossRefPubMed
Metadata
Title
The influence of patient variables on insulin total daily dose in paediatric inpatients with new onset type 1 diabetes mellitus
Authors
Marion Muller
Benjamin J. Wheeler
Miranda Blackwell
Mathilde Colas
David M. Reith
Natalie J. Medlicott
Hesham S. Al-Sallami
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2018
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-018-0355-5

Other articles of this Issue 2/2018

Journal of Diabetes & Metabolic Disorders 2/2018 Go to the issue